Was great, now average - Associate Director MSD Employee Review

4.0
Apr 24, 2025
Recommend
CEO approval
Business Outlook

Pros

Decent pay, good team, nice offices

Cons

As key drug Keytruda approaches end of patent, company is in flux. Cost cutting and pressure increase.

Explore other reviews about MSD

5.0
Jun 2, 2026
Recommend
CEO approval
Business Outlook

Pros

Work culture Fantastic colleagues Sense of purpose

Cons

Location: Not in west coast

5.0
May 20, 2026
Recommend
CEO approval
Business Outlook

Pros

Strong processes and focus on excellence

Cons

Large company is slower to pivot, makes innovation more difficult

See reviews by: Helpful|Rating|Date|All